Back
Greenbrier Companies Vs. Viking Therapeutics Industry Stock Comparison
Buy
79
GBX
Greenbrier Companies
Last Price:
61.16
Seasonality Move:
-0.14%
Buy
66
VKTX
Viking Therapeutics
Last Price:
78.07
Seasonality Move:
23.93%
Buy
79
Greenbrier Companies (GBX)
is a Buy
Is Greenbrier Companies a Buy, Sell or Hold?
- The current Greenbrier Companies [GBX] share price is $60.03. The Score for GBX is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.
- GBX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
66
Viking Therapeutics (VKTX)
is a Buy
Is Viking Therapeutics a Buy, Sell or Hold?
- The current Viking Therapeutics [VKTX] share price is $73.22. The Score for VKTX is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
- VKTX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GBX Stock Price Chart
What is Greenbrier Companies's stock price today?
-
The Greenbrier Companies share price today is $60.03
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GBX is experiencing buying pressure, which is a positive indicator for future bullish movement.
VKTX Stock Price Chart
What is Viking Therapeutics's stock price today?
-
The Viking Therapeutics share price today is $73.22
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VKTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
GBX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.51 | Buy |
| Relative Strength Index (14 RSI): | 78.56 | Buy |
| Chaikin Money Flow: | 1205681 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (48.94 - 53.2) | Buy |
| Bollinger Bands (100): | (46.29 - 51.51) | Buy |
VKTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.97 | Buy |
| Relative Strength Index (14 RSI): | 63.67 | Buy |
| Chaikin Money Flow: | 9568250 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (61.78 - 67.44) | Buy |
| Bollinger Bands (100): | (52.78 - 64.52) | Buy |
GBX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 53 | Buy |
| 20-day SMA: | 51.13 | Buy |
| 50-day SMA: | 49.09 | Buy |
| 200-day SMA: | 49.49 | Buy |
| 8-day EMA: | 53.48 | Buy |
| 20-day EMA: | 51.68 | Buy |
| 50-day EMA: | 50.04 | Buy |
| 200-day EMA: | 47.98 | Buy |
VKTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 65.35 | Buy |
| 20-day SMA: | 64.33 | Buy |
| 50-day SMA: | 62.98 | Buy |
| 200-day SMA: | 58.03 | Buy |
| 8-day EMA: | 65.61 | Buy |
| 20-day EMA: | 64.61 | Buy |
| 50-day EMA: | 62.82 | Buy |
| 200-day EMA: | 54.1 | Buy |
Greenbrier Companies Earnings Growth & GBX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.37 per share, and an increase next year of $0.78 per share.
Viking Therapeutics Earnings Growth & VKTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.05 per share, and a decrease next year of $0.45 per share.
Greenbrier Companies Technical Analysis
| Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Viking Therapeutics Technical Analysis
| Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||